<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7707449</journal-id>
<journal-id journal-id-type="pubmed-jr-id">656</journal-id>
<journal-id journal-id-type="nlm-ta">Ann Neurol</journal-id>
<journal-id journal-id-type="iso-abbrev">Ann. Neurol.</journal-id>
<journal-title-group>
<journal-title>Annals of neurology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0364-5134</issn>
<issn pub-type="epub">1531-8249</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27130255</article-id>
<article-id pub-id-type="pmc">4938747</article-id>
<article-id pub-id-type="doi">10.1002/ana.24678</article-id>
<article-id pub-id-type="manuscript">NIHMS783562</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title><italic>PYCR2</italic> mutations cause a lethal syndrome of microcephaly and failure to thrive</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zaki</surname>
<given-names>Maha S.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bhat</surname>
<given-names>Gifty</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sultan</surname>
<given-names>Tipu</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Issa</surname>
<given-names>Mahmoud</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jung</surname>
<given-names>Hea-Jin</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dikoglu</surname>
<given-names>Esra</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Selim</surname>
<given-names>Laila</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gamal</surname>
<given-names>Imam</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Abdel-Hamid</surname>
<given-names>Mohamed S.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Abdel-Salam</surname>
<given-names>Ghada</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Marin-Valencia</surname>
<given-names>Isaac</given-names>
</name>
<degrees>MD, MS</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gleeson</surname>
<given-names>Joseph G.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Clinical Genetics Department, Human Genetics and Genome Research Division, National Research Centre, Cairo, Egypt 12311</aff>
<aff id="A2"><label>2</label>Laboratory for Pediatric Brain Disease, Howard Hughes Medical Institute, The Rockefeller University, New York, NY 10065</aff>
<aff id="A3"><label>3</label>Division of Pediatric Genetics, The Children’s Hospital at Montefiore, Bronx, NY 10467</aff>
<aff id="A4"><label>4</label>Pediatric Neurology, Institute of Child Health, The Children Hospital, Lahore, Pakistan</aff>
<aff id="A5"><label>5</label>Cairo Children’s Hospital, Cairo University, Cairo, Egypt 12311</aff>
<aff id="A6"><label>6</label>Department of Medical Molecular Genetics, Human Genetics and Genome Research Division, National Research Center Cairo, Egypt 12311</aff>
<author-notes>
<corresp id="FN1">Address for correspondence: <email>dr_mahazaki@yahoo.com</email> or <email>jogleeson@rockefeller.edu</email>, Tel: 858-682-9011</corresp>
<fn fn-type="conflict" id="FN3">
<p>
<bold>Potential Conflicts of Interest</bold>
</p>
<p>Nothing to report.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>6</day>
<month>5</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>01</day>
<month>6</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>7</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>7</month>
<year>2017</year>
</pub-date>
<volume>80</volume>
<issue>1</issue>
<fpage>59</fpage>
<lpage>70</lpage>
<!--elocation-id from pubmed: 10.1002/ana.24678-->
<abstract>
<sec id="S1">
<title>Objective</title>
<p id="P1">A study was undertaken to characterize the clinical features of the newly described hypomyelinating leukodystrophy type 10 with microcephaly. This is an autosomal recessive disorder mapped to chromosome 1q42.12 due to mutations in <italic>PYCR2</italic> gene, encoding an enzyme involved in proline synthesis in mitochondria.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P2">From several international clinics, eleven consanguineous families were identified with <italic>PYCR2</italic> mutations by whole exome or targeted sequencing, with detailed clinical and radiological phenotyping. Selective mutations from patients were tested for effect on protein function.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">The characteristic clinical presentation of patients with <italic>PYCR2</italic> mutations included failure to thrive, microcephaly, craniofacial dysmorphism, progressive psychomotor disability, hyperkinetic movements, and axial hypotonia with variable appendicular spasticity. Patients did not survive beyond the first decade of life. Brain magnetic resonance imaging (MRI) showed global brain atrophy and white matter T2 hyperintensities. Routine serum metabolic profiles were unremarkable. Both nonsense and missense mutations were identified, which impaired protein multimerization.</p>
</sec>
<sec id="S4">
<title>Interpretation</title>
<p id="P4"><italic>PYCR2</italic>-related syndrome represents a clinically recognizable condition in which <italic>PYCR2</italic> mutations lead to protein dysfunction, not detectable on routine biochemical assessments. Mutations predict a poor outcome, probably as a result of impaired mitochondrial function.</p>
</sec>
</abstract>
<kwd-group>
<kwd>PYCR2</kwd>
<kwd>hypomyelinating leukodystrophy-10</kwd>
<kwd>brain atrophy</kwd>
<kwd>microcephaly</kwd>
<kwd>pyrroline-5-carboxylate reductase 2</kwd>
<kwd>proline metabolism</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>